news aktuell GmbH

Competition for the CIVIS Media Prize 2026 opened: Submissions possible until 31 December 2025

31.10.2025 10:00:00 CET | news aktuell GmbH | Press Release

Share

Submissions possible until 31 December 2025

31.10.2025 – Cologne (ots) | The competition for the European CIVIS Media Prize 2026 is open. Until 31 December 2025, media professionals from all EU countries and Switzerland can submit entries online on the topics of migration, integration, cultural diversity and - related to this - social cohesion.

The CIVIS Media Prize honours outstanding journalistic achievements in television, radio, the internet and social media that promote the peaceful coexistence of people from different geographical and cultural backgrounds. The prize is endowed with a total of 27,000 euros. Nine CIVIS AWARDS are awarded in different categories.

Further information on the CIVIS Media Prize 2026 can be found here.

Click here to register.

The CIVIS Media Prize is sponsored by ARD, represented by WDR, together with the Freudenberg Foundation. ORF, SRG SSR, ARTE, 3sat, Deutsche Welle, Deutschlandradio and the EBU are media partners. WDR mediagroup, Produktionsallianz, VFF Verwertungsgesellschaft der Film- und Fernsehproduzenten, the European Union Agency for Fundamental Rights (FRA), Deutsche Postcode Lotterie and the Harald Christ Foundation for Democracy and Diversity are co-operation partners.

The competition, the jury meetings and the award ceremony are organised by the non-profit CIVIS Media Foundation in Cologne.

The European CIVIS Media Prize is intended to encourage media professionals to address the topics of migration, integration, cultural diversity and social cohesion in a creative, constructive and - where necessary - (self-)critical manner.

Follow CIVIS on Facebook | Instagram | LinkedIn | YouTube

#civis2026

Click here for the conditions of participation for the CIVIS Media Prize 2026.

ENDE PM

Bitte folgende Links im Text verwenden:

TEXT

Link

online

https://registration.civismedia.eu/

categories

https://www.civismedia.eu/en/media-prize/media-prize-2026/price-categories

here

https://www.civismedia.eu/en/media-prize/media-prize-2026/overview

register

https://registration.civismedia.eu/

Facebook

https://www.facebook.com/civismediaprize

Instagram

https://www.instagram.com/civis_medienstiftung/

LinkedIn

https://www.linkedin.com/company/civis-medienstiftung/

YouTube

https://www.youtube.com/@civis_media

conditions of Participation

https://www.civismedia.eu/en/media-prize/media-prize-2026/conditions-of-participation/

civismedia.eu

https://www.civismedia.eu/en/

Contacts

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:28:38 CEST | Press Release

New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found. The report, “The Governance Performance of the Fifty States: The U.S. Berggruen Governance Index”, applies the research team’s “governance triangle” from past global country rankings to the 50 US states. The report has now been presented to the public at Columbia University in New York. “Unlike in the Berggruen Governance Index’s cross-national comparisons, where the three dimensions are broadly correlated, in the 50 U.S. states they often run counter to each other,” the authors conclude. “This may seem counterintuitive, as one might expect a well-governed state to finish high on all three and a poor

Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 09:23:41 CEST | Press Release

Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye